Drug development against tuberculosis: Past, present and future

Article ID	Journal	Published Year	Pages	File Type
5672317	Indian Journal of Tuberculosis	2017	24 Pages	PDF

Keywords

PZA LFT MTB XDR-TB MDR-TB CBC FDA GLP MRC FQs MIC CDC CyP TDR-TB rRNA NADP INH EMB Ethionamide Per os Ribosomal RNA Liver function test ethambutol eth isoniazid Tuberculosis Good Laboratory Practice Drug development Minimum inhibitory concentration Gastrointestinal Rifampicin World Health Organization Food and Drug Administration multi-drug resistant tuberculosis cytochrome Medical Research Council Antimicrobials Fluoroquinolones Mycobacterium tuberculosis Centers for Disease Control and Prevention Drug resistance nicotinamide adenine dinucleotide phosphate Catalase-peroxidase katG Rif WHO

Related Topics

Health Sciences Medicine and Dentistry Infectious Diseases

Drug development against tuberculosis: Past, present and future

Authors

Mahesh S. Vasava, Manoj N. Bhoi, Sanjay K. Rathwa, Mayuri A. Borad, Sneha G. Nair, Hitesh D. Patel,